Human carcinogenic risk assessment based on hormonal effects in a carcinogenicity study in rats with the antifungal agent, fluconazole
- 1 January 1994
- journal article
- Published by Wiley in Teratogenesis, Carcinogenesis, and Mutagenesis
- Vol. 14 (6) , 251-257
- https://doi.org/10.1002/tcm.1770140602
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- FluconazoleDrugs, 1990
- Fluconazole and testosterone: in vivo and in vitro studiesAntimicrobial Agents and Chemotherapy, 1988
- The Rat Adrenal Medulla. II. Proliferative LesionsJournal of the American College of Toxicology, 1988
- National Toxicology Program Nomenclature for Hepatoproliferative Lesions of RatsToxicologic Pathology, 1986
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985
- Effect of a high dosage of ketoconazole all or not combined with ovariectomy on N-nitroso-N-methylurea-induced mammary cancer in the ratCancer Letters, 1984
- Choline Deficiency, Partial Hepatectomy, and Liver Tumors in Rats and MiceToxicologic Pathology, 1982
- Experimental Diffuse Nodular Hepatic HyperplasiaToxicologic Pathology, 1982
- Response of liver foci in rats to hepatic tumor promotersToxicologic Pathology, 1982
- Physiological And Biochemical Reviews Of Sex Differences And Carcinogenesis With Particular Reference To The LiverAdvances in Cancer Research, 1973